SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000904454-13-000070
Filing Date
2013-01-23
Accepted
2013-01-23 14:07:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A NO. 2 FOR AEGERION PHARMACEUTICALS, INC. s13da_012313-aegerion.htm SC 13D/A 136004
  Complete submission text file 0000904454-13-000070.txt   137599
Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85739 | Film No.: 13542408
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ
Business Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ 441534605643
Index Venture Associates III Ltd (Filed by) CIK: 0001503683 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13D/A